Advertisement
Screener

SELLAS Life Sciences Group, Inc. (SLS) Shareholder Equity

SELLAS Life Sciences Group, Inc. (SLS) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $20.00K; Additional Paid in Capital, Common StockUSD $430.64M; Retained Earnings (Accumulated Deficit)USD $-293.00M.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $18.00K; Additional Paid in Capital, Common StockUSD $390.79M; Retained Earnings (Accumulated Deficit)USD $-283.39M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $15.00K; Additional Paid in Capital, Common StockUSD $345.84M; Retained Earnings (Accumulated Deficit)USD $-274.99M.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $12.00K; Additional Paid in Capital, Common StockUSD $312.95M; Retained Earnings (Accumulated Deficit)USD $-267.33M.

SELLAS Life Sciences Group, Inc. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital, Common Stock
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Treasury Stock, Value
USD
Accumulated Other Comprehensive Income (Loss), Net of Tax
USD
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
USD
Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt
USD
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation
USD
Adjustments to Additional Paid in Capital, Share-based Compensation, Nonvested Shares, Requisite Service Period Recognition (Deprecated 2013-01-31)
USD
Treasury Stock, Shares
shares
2026-06-30(m)$20.00K$430.64M$-293.00M$137.66M3 month · $1.01M
6 month · $1.81M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2026-03-31(m)$18.00K$390.79M$-283.39M$107.41M3 month · $798.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-12-31(m)$15.00K$345.84M$-274.99M$70.87M12 month · $1.96M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30(m)$12.00K$312.95M$-267.33M$45.63M3 month · $503.00K
9 month · $1.51M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-06-30(m)$10.00K$286.68M$-260.54M$26.15M3 month · $501.00K
6 month · $1.01M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-03-31(m)$9.00K$281.69M$-253.94M$27.76M3 month · $505.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-12-31(m)$7.00K$257.58M$-248.12M$9.46M12 month · $1.56M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30$0.00$6.00K$257.27M$-241.39M$15.89M3 month · $381.00K
9 month · $1.19M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-06-30$0.00$5.00K$237.19M$-234.28M$2.91M3 month · $334.00K
6 month · $810.00K
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-03-31$0.00$5.00K$236.49M$-226.81M$9.68M3 month · $476.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-12-31$0.00$3.00K$209.26M$-217.24M$-7.98M12 month · $2.09M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30$0.00$3.00K$205.28M$-209.11M$-3.83M3 month · $543.00K
9 month · $1.60M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-06-30$0.00$3.00K$204.68M$-199.84M$4.84M3 month · $514.00K
6 month · $1.05M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-03-31$0.00$3.00K$204.17M$-191.00M$13.17M3 month · $540.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-12-31$0.00$2.00K$184.75M$-179.90M$4.85M12 month · $1.73M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30$0.00$2.00K$183.38M$-170.78M$12.60M3 month · $455.00K
9 month · $1.28M
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-06-30$0.00$2.00K$182.82M$-163.76M$19.06M3 month · $450.00K
6 month · $825.00K
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-03-31$0.00$2.00K$159.37M$-155.35M$4.03M3 month · $375.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-12-31$0.00$2.00K$158.95M$-138.60M$20.35M12 month · $1.01M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30$0.00$2.00K$158.61M$-132.00M$26.61M3 month · $275.00K
9 month · $723.00K
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-06-30$0.00$2.00K$158.33M$-124.92M$33.41M3 month · $264.00K
6 month · $448.00K
(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-03-31$0.00$2.00K$149.05M$-120.31M$28.74M3 month · $184.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-12-31$0.00$1.00K$145.86M$-117.90M$27.96M12 month · $578.00K(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30$0.00$10.00K$122.13M$-114.19M$7.95M3 month · $146.00K
9 month · $437.00K
(m)(m)$7.95M(m)(m)(m)(m)(m)(m)(m)(m)
2020-06-30$0.00$7.00K$113.49M$-109.72M$3.78M3 month · $146.00K
6 month · $291.00K
(m)(m)$3.78M(m)(m)(m)(m)(m)(m)(m)(m)
2020-03-31$0.00$7.00K$113.34M$-105.29M$8.06M3 month · $145.00K(m)(m)$8.06M(m)(m)(m)(m)(m)(m)(m)(m)
2019-12-31$0.00$1.00K$107.24M$-101.15M$6.09M12 month · $573.00K(m)(m)$6.09M(m)(m)(m)(m)(m)12 month · $573.00K(m)(m)
2019-09-30$0.00$5.00K$104.36M$-93.73M$10.64M3 month · $115.00K
9 month · $426.00K
(m)(m)$10.64M(m)(m)(m)(m)(m)(m)(m)(m)
2019-06-30$0.00$10.00K$103.85M$-89.53M$14.34M3 month · $126.00K
6 month · $311.00K
(m)(m)$14.34M(m)(m)(m)(m)(m)3 month · $126.00K
6 month · $311.00K
(m)(m)
2019-03-31$0.00$2.00K$89.34M$-86.39M$2.95M3 month · $185.00K(m)(m)$2.95M(m)(m)(m)(m)(m)3 month · $185.00K(m)(m)
2018-12-31$0.00$1.00K$87.10M$-81.86M$5.25M(m)(m)(m)$5.25M(m)(m)(m)12 month · $-4.44M12 month · $-5.04M12 month · $395.00K(m)(m)
2018-09-30$0.00$2.00K$86.99M$-68.53M$18.46M3 month · $136.00K
9 month · $284.00K
(m)(m)$18.46M9 month · $825.00K(m)(m)9 month · $-4.44M9 month · $-5.04M9 month · $284.00K(m)(m)
2018-06-30$0.00$1.00K$65.76M$-68.24M$-2.48M(m)(m)(m)$-2.48M(m)(m)(m)3 month · $-2.47M
6 month · $-4.44M
3 month · $2.45M
6 month · $5.04M
3 month · $125.00K
6 month · $147.00K
(m)(m)
2018-03-31$0.00$1.00K$60.86M$-62.18M$-1.32M(m)(m)(m)$-1.32M(m)(m)(m)3 month · $-1.97M3 month · $2.59M3 month · $22.00K(m)(m)
2017-12-31$0.00$1.00K$56.25M$-54.19M$2.07M(m)(m)(m)$2.07M(m)(m)12 month · $3.17M(m)(m)(m)(m)(m)
2017-09-30$0.00$4.00K$347.61M$-329.13M$14.64M(m)$3.85M(m)$14.64M(m)9 month · $356.00K(m)(m)9 month · $10.36M9 month · $576.00K(m)33.75K
2017-06-30$0.00$4.00K$346.03M$-323.05M$19.13M(m)$3.85M(m)$19.13M(m)6 month · $356.00K(m)(m)6 month · $10.36M6 month · $425.00K(m)33.75K
2017-03-31(m)$4.00K$345.69M(m)$27.19M(m)$3.85M(m)$27.19M(m)3 month · $356.00K(m)(m)3 month · $10.36M3 month · $228.00K(m)675.00K
2016-12-31$0.00$2.00K$25.43M$-30.43M$-5.00M(m)$3.85M(m)$-5.00M(m)(m)12 month · $354.00K(m)12 month · $-9.89M12 month · $2.26M(m)33.75K
2016-09-30(m)$20.00K$325.18M(m)$23.93M(m)$3.85M(m)$23.93M(m)(m)(m)(m)9 month · $9.89M9 month · $1.83M(m)675.00K
2016-06-30(m)$18.00K$314.64M(m)$20.32M(m)$3.85M(m)$20.32M(m)(m)(m)(m)6 month · $5.59M6 month · $1.28M(m)675.00K
2016-03-31(m)$18.00K$312.12M(m)$12.41M(m)$3.85M(m)$12.41M(m)(m)(m)(m)3 month · $5.59M3 month · $656.00K(m)675.00K
2015-12-31(m)$15.00K$296.73M(m)$-12.26M(m)$3.85M(m)$13.51M(m)(m)(m)(m)12 month · $-10.30M12 month · $2.90M(m)33.75K
2015-09-30(m)$15.00K$295.96M(m)$32.42M(m)$3.85M(m)$32.42M(m)(m)(m)(m)(m)9 month · $2.12M(m)675.00K
2015-06-30(m)$15.00K$294.88M(m)$49.37M(m)$3.85M(m)$49.37M(m)(m)(m)(m)(m)6 month · $1.27M(m)675.00K
2015-03-31(m)$15.00K$288.94M(m)$59.08M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2014-12-31(m)$12.00K$256.38M(m)$37.06M(m)$3.85M(m)$37.06M(m)(m)12 month · $134.00K(m)(m)12 month · $5.25M(m)675.00K
2014-09-30(m)$11.00K$242.22M(m)$30.86M9 month · $138.00K$3.85M(m)$59.08M(m)(m)(m)(m)(m)9 month · $627.00K(m)675.00K
2014-06-30(m)$11.00K$233.50M(m)$28.31M6 month · $158.00K$3.85M(m)$28.31M(m)(m)(m)(m)(m)6 month · $2.98M(m)675.00K
2014-03-31(m)$11.00K$231.75M(m)$46.50M3 month · $75.00K$3.85M(m)$46.50M(m)(m)(m)(m)(m)3 month · $1.55M(m)675.00K
2013-12-31(m)$10.00K$188.60M(m)$5.89M12 month · $644.00K$3.85M$0.00$5.89M(m)(m)12 month · $644.00K(m)(m)12 month · $1.89M(m)675.00K
2013-09-30(m)$10.00K$167.11M(m)$34.62M9 month · $67.00K$3.85M$1.72M$34.62M(m)(m)(m)(m)(m)9 month · $1.07M(m)675.00K
2013-06-30(m)$8.00K$136.65M(m)$15.23M(m)$3.85M$3.51M(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2013-03-31(m)$8.00K$132.75M(m)$23.31M(m)$3.85M$5.89M(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2012-12-31(m)$8.00K$132.17M(m)$27.76M(m)$3.85M$1.63M$27.76M(m)(m)12 month · $600.00K(m)12 month · $-7.29M12 month · $794.00K12 month · $794.00K675.00K
2012-09-30$0.00$7.00K$116.45M(m)$14.16M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2012-06-30(m)$7.00K$115.14M(m)$19.12M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2012-03-31(m)$5.00K$85.26M(m)$-10.57M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2011-12-31$0.00$5.00K$81.18M(m)$10.11M(m)$3.85M(m)$10.11M(m)(m)12 month · $-15.00K(m)12 month · $-12.71M(m)12 month · $2.77M675.00K
2011-09-30(m)$4.00K$77.37M(m)$4.71M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2011-06-30$0.00$4.00K$74.32M$-60.97M$7.13M(m)$3.85M(m)(m)(m)(m)(m)(m)(m)(m)(m)675.00K
2010-12-31$0.00$2.00K$62.02M$-55.74M$2.43M(m)$3.85M(m)$2.43M(m)(m)(m)(m)(m)(m)(m)675.00K

Similar stocks

Stock NameCountryMarket CapPE Ratio
uniQure N.V. (QURE)$2.416B-4.93
Vera Therapeutics, Inc. (VERA)United States$2.402B-7.67
Harmony Biosciences Holdings, Inc. (HRMY)United States$2.399B11.67
Nurix Therapeutics, Inc. (NRIX)United States$2.457B-5.39
Mineralys Therapeutics, Inc. (MLYS)United States$2.353B-6.82
Viridian Therapeutics, Inc.\DE (VRDN)United States$2.342B-5.38
SUPERNUS PHARMACEUTICALS, INC. (SUPN)United States$2.517B-24.63
Immunome Inc. (IMNM)United States$2.538B-9.45
Disc Medicine, Inc. (IRON)United States$2.553B-11.40
Zai Lab Ltd (ZLAB)$2.241B-113.34